Though more research is needed to understand who might benefit from GLP-1 agonists for addiction, early studies suggest that the approach holds promise.

A decision about how to spend settlement funds in Carter County, Kentucky, which was hit hard by the opioid epidemic, offers ...

A randomized, placebo-controlled trial validates a side effect frequently observed by doctors and patients. A new study from ...

Researchers have debunked key beliefs about addiction, like that a person must hit "rock bottom" before having treatment or ...

Oregonians are cautiously optimistic about the state’s new approach to helping people addicted to drugs, but they remain worried that people still struggle to access limited services for treatment, a ...

As the opioid crisis continues to challenge the Appalachian Highlands and communities nationwide, Ballad Health and East ...

President Donald Trump and HHS Secretary Robert F. Kennedy Jr. said they will be studying the "threat" to children posed by ...

Ozempic may also help people drink less alcohol. Primary care doctors are concerned about patients accessing GLP-1s through ...

Glucagon-like peptide receptor agonists (GLP-1RAs) like Novo Nordisk’s semaglutide (Ozempic, Wegovy) and Eli Lilly’s ...

Addiction affects more than just the individual struggling with substance abuse; it impacts the entire family. Loved ones ...

A new clinical trial showed promising results in curbing alcohol cravings in individuals with moderate alcohol-use disorder.

"Love Is Blind" contestant Devin Buckley admits to being addicted to ibuprofen. But is that possible? Here, MDs explain ...